Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,107 across all filing types
Latest filing 2026-06-10 Proxy Solicitation & In…
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
AGM Voting
Proxy Solicitation & Information Statement Classification · 81% confidence The document is an RNS announcement detailing the arrangements and instructions for Novacyt’s upcoming Annual General Meeting, specifically guiding shareholders on proxy voting, advance voting methods, and attendance. It serves to provide meeting information and solicit votes rather than reporting results or publishing financials. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to inform them of and request their votes at a meeting.
2026-06-10 English
Vote en Assemblée Générale
Proxy Solicitation & Information Statement Classification · 75% confidence The document is a public announcement detailing the logistics for the upcoming Ordinary and Extraordinary General Meeting (AGM) on June 30, 2026, including how shareholders can vote in advance, submit proxies, and attend (in person or via webinar). It does not contain any financial statements or results, nor is it a full AGM presentation. Instead, it provides information and procedural instructions to shareholders to facilitate proxy voting at the meeting, which aligns with the definition of a Proxy Solicitation & Information Statement.
2026-06-10 French
Liquidity Agreement Monthly Update and TVR
Transaction in Own Shares Classification · 75% confidence The document is an RNS announcement providing a monthly liquidity agreement update, showing the number of shares purchased and sold under the liquidity agreement and the treasury share balance, plus a total voting rights figure. This is a report of the company’s own share transactions (buybacks and sales under a liquidity agreement), fitting the definition of Transaction in Own Shares (POS).
2026-06-01 English
Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote
Transaction in Own Shares Classification · 87% confidence The document is a monthly reporting of actions executed under the liquidity contract (shares bought and sold by Invest Securities for Novacyt) and the total number of shares and voting rights outstanding. This is a report of transactions in own shares rather than an announcement of dividends, board changes, or a full financial report. Therefore it falls under the “Transaction in Own Shares” category (POS).
2026-06-01 French
Operational Update
Regulatory Filings Classification · 90% confidence The document is an RNS (Regulatory News Service) announcement by Novacyt S.A. providing an operational update and inside information under MAR. It does not contain financial statements, earnings figures or details of any specific transaction, nor does it fit any specialized category (e.g., earnings release, M&A, management change). It is a general regulatory announcement, so it is classified as Regulatory Filings (RNS).
2026-06-01 English
Mise à jour opérationnelle
Regulatory Filings Classification · 82% confidence The document is a press release styled as an "operational update" disclosing inside information (EU Market Abuse Regulation) about proposed cost-reduction measures and workforce restructuring. It does not contain financial statements, earnings highlights, or formal report content, nor is it a call transcript, proxy notice, or remuneration statement. It is a general regulatory announcement and thus best fits into the Regulatory Filings (RNS) category.
2026-06-01 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.